Fresenius SE & Co. KGaA

Price Chart

Risk-Adjusted Performance

Also Listed On

Fresenius SE & Co. KGaA (FRE) Price Performance

Fresenius SE & Co. KGaA (FRE) trades on XETRA (Frankfurt) in EUR. The company is classified in the Healthcare sector under the Medical Care Facilities industry. The stock currently trades at EUR43.69, down 5.12% from the previous close.

Over the past year, FRE has traded between a low of EUR34.35 and a high of EUR52.12. The stock has gained 11.9% over this period. It is currently 16.2% below its 52-week high.

Fresenius SE & Co. KGaA has a market capitalization of $26.37B, with a price-to-earnings ratio of 22.84 and a dividend yield of 2.15%.

About Fresenius SE & Co. KGaA

Fresenius SE & Co. KGaA, a health care company, provides products and services for chronically ill patients. It operates through Fresenius Kabi and Fresenius Helios segment. The Fresenius Kabi segment engages in the therapy and care of critically and chronically ill patients; enteral and parenteral nutrition products; medical technologies, as well as disposables, infusions pumps, apheresis machines, cell therapy devices, and other products. The Fresenius Helios segment provides clinical and nursing care facilities. The company was formerly known as Fresenius SE and changed its name to Fresenius SE & Co. KGaA in January 2011. Fresenius SE & Co. KGaA was founded in 1912 and is based in Bad Homburg vor der Höhe, Germany.